Vimarsana
Biggest News Aggregation in the World

Romain Attard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Romain Attard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Romain Attard Today - Breaking & Trending Today

TISSIUM Selected for the French Tech 120 Program - Vimarsana News

TISSIUM Selected for the French Tech 120 Program

For the fifth year in a row PARIS, FRANCE / ACCESSWIRE / May 22, 2024 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection

First Patients Treated with TISSIUM's Atraumatic Hernia Repair System - Vimarsana News

First Patients Treated with TISSIUM's Atraumatic Hernia Repair System

TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue repair, announced today the first clinical use of TISSIUM's Adhesive Hernia Repair System (the "ECLIPSIUM System") in patients undergoing laparoscopic ventral hernia repair as part of the ALPHA clinical study taking place in Belgium.

Source: yahoo.com
TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch ... - Vimarsana News

TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch ...

TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch ...

First Patients Treated with TISSIUM's Atraumatic Sutureless Nerve Coaptation ... 2023-03-30 - Vimarsana News

First Patients Treated with TISSIUM's Atraumatic Sutureless Nerve Coaptation ... 2023-03-30

First Patients Treated with TISSIUM’s Atraumatic Sutureless Nerve Coaptation ...

First Patients Treated with TISSIUM's Atraumatic Sutureless Nerve Coaptation System - Vimarsana News

First Patients Treated with TISSIUM's Atraumatic Sutureless Nerve Coaptation System

Clinical Study of TISSIUM's COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in AustraliaPARIS, FRANCE and BOSTON, MA / ACCESSWIRE / March 30, 2023 / TISSIUM, a privately-owned